Curaleaf Holdings, Inc. Stock price Canadian Securities Exchange

Equities

CURA

CA23126M1023

Pharmaceuticals

End-of-day quote Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Curaleaf Holdings, Inc. -10.77% -10.46%
Sales 2024 * 1.42B 1.93B Sales 2025 * 1.58B 2.14B Capitalization 4.03B 5.46B
Net income 2024 * -89M -120M Net income 2025 * -7M -9.47M EV / Sales 2024 * 3.16 x
Net Debt 2024 * 474M 642M Net Debt 2025 * 802M 1.08B EV / Sales 2025 * 3.06 x
P/E ratio 2024 *
-38.7 x
P/E ratio 2025 *
-85.4 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 60.39%
More Fundamentals * Assessed data
Dynamic Chart
Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, and Grassroots provide service, product selection and accessibility across the medical and adult-use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. Curaleaf International is an integrated cannabis company in Europe with a supply and distribution network throughout the European market. It also offers Can4Med, a pharmaceutical wholesaler specializing in cannabinoid medications in Poland. Curaleaf is the national retail dispensary brand in the United States and a mainstream cannabis brand available in multiple states and product formats: vape oils and concentrates, flower, pre rolls and flower pod, topical lotions, capsules and tinctures, mints and lozenges and edibles.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
5.467 USD
Average target price
7.767 USD
Spread / Average Target
+42.07%
Consensus
  1. Stock
  2. Equities
  3. Stock Curaleaf Holdings, Inc.
  4. Stock Curaleaf Holdings, Inc. - Canadian Securities Exchange